Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intracoronary Infusion of Concentrated Autologous Bone Marrow Mononuclear Cells in Acute Myocardial Infarction Patients Utilizing a Novel Point-of-Care Device for Rapid-Delivery of Stem Cells (AMIRST)

NCT01536106 is registered in ClinicalTrials.gov with TotipotentRX Cell Therapy Pvt. Ltd. as lead sponsor.

NCT NCT01536106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01536106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intracoronary Infusion of Concentrated Autologous Bone Marrow Mononuclear Cells in Acute Myocardial Infarction Patients Utilizing a Novel Point-of-Care Device for Rapid-Delivery of Stem Cells (AMIRST)
Lead sponsor
TotipotentRX Cell Therapy Pvt. Ltd.
Phase
Phase 1/2
Overall status
Unknown status
Start date
December 31, 2013
Completion date
March 31, 2015
Enrollment
30 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction